← All trials
NCT02707458
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2016
- Primary completion
- Mar 1, 2018
- Completion date
- May 1, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 23
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- McGill UniversityLead sponsor
- McGill UniversityOverall official - principal investigator
- McGill UniversityReponsible party - principal investigator
- McGill UniversityCollaborator
- Weston Brain InstituteCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.